Pathways | MLL | t(8;21) | inv(16) | t(15;17) | NUP98.NSD1 | CEPBA.dm | NPM1 |
---|
AGR | | | | |
|
| |
ALK |
| | | | | | |
AT1R |
| | | | | | |
ATRBRCA | | | | |
| | |
BCR | |
| | | | | |
BIOPEPTIDES | | |
| | | | |
CELLCYCLE | | | | |
| | |
CHREBP2 | | | | |
| |
|
EIF | | | | |
| | |
FCER1 | |
| | | | | |
GPCR | | |
| | | | |
INTEGRIN | |
| | | | | |
KERATINOCYTE |
| |
|
|
| | |
MAPK | | | |
| |
|
|
NO1 | | | | |
| | |
P38MAPK | | | | |
|
|
|
PPARA | | | |
| |
| |
TNFR1 | | | | | | 0.000 | |
- In each column, numbers denote the difference between the mean RMS of samples in a particular subtype and the mean RMS of remaining samples (e.g. RMS
MLL
- RMS
Rest
). Numbers in red denote the pathway is tightly regulated in a subtype compared to the test, and opposite applies to the pathway in blue